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Abstract
Green fluorescent protein (GFP) has undergone a long history of optimization to become one of the most popular proteins
in all of cell biology. It is thermally and chemically robust and produces a pronounced fluorescent phenotype when
expressed in cells of all types. Recently, a superfolder GFP was engineered with increased resistance to denaturation and
improved folding kinetics. Here we report that unlike other well-folded variants of GFP (e.g., GFPmut2), superfolder GFP was
spared from elimination when targeted for secretion via the SecYEG translocase. This prompted us to hypothesize that the
folding quality control inherent to this secretory pathway could be used as a platform for engineering similar ‘superfolded’
proteins. To test this, we targeted a combinatorial library of GFPmut2 variants to the SecYEG translocase and isolated several
superfolded variants that accumulated in the cytoplasm due to their enhanced folding properties. Each of these GFP
variants exhibited much faster folding kinetics than the parental GFPmut2 protein and one of these, designated superfast
GFP, folded at a rate that even exceeded superfolder GFP. Remarkably, these GFP variants exhibited little to no loss in
specific fluorescence activity relative to GFPmut2, suggesting that the process of superfolding can be accomplished without
altering the proteins’ normal function. Overall, we demonstrate that laboratory evolution combined with secretory pathway
quality control enables sampling of largely unexplored amino-acid sequences for the discovery of artificial, high-
performance proteins with properties that are unparalleled in their naturally occurring analogues.
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Introduction
The green fluorescent protein (GFP) from Aequorea jellyfish [1] is
inefficiently folded when expressed in Escherichia coli [2,3]. To
address this problem, several folding-enhanced variants of GFP
have been created over the years that have effectively elevated GFP
to one of the most studied and exploited proteins in biochemistry
and cell biology [2,4]. Recently, two studies reported the creation of
GFP superproteins. Superproteins are best defined as high-
performance proteins that ignore at least some biologically imposed
restrictions on amino acid sequence and occupy regions of sequence
space unexplored by naturally occurring proteins optimized for in
vivo function [5,6]. For instance, Waldo and coworkers reported the
engineering of a superfolder GFP (sfGFP) that showed improved
tolerance to circular permutation, increased resistance to denatur-
ation, improved folding kinetics, and increased resistance to
aggregation during refolding [7,8]. sfGFP has proven to be very
useful as a scaffold for improved protein detection and tagging both
in vivo and in vitro using self-assembled sfGFP fragments [9,10] and
for peptide insertions that confer binding activity to sfGFP giving
rise to so-called fluorobodies [11]. Along similar lines, Liu and
coworkers recently engineered supercharged versions of sfGFP
whosenet chargewasaltered byasmuchas+48chargeunitsand,as
a result, remained soluble even when exposed to conditions that
strongly favored aggregation [12].
Remarkably, almost ten years elapsed between the publication
of the sfGFP sequence and the original folding-optimized ‘cycle 3’
mutant GFP [2]. This notable lag led us and others [13] to
question whether this was due to inherent difficulties in
engineering folding-enhanced variants of GFP or whether
methods of screening and selecting were limiting progress. Indeed,
the creation of both sfGFP and supercharged GFP revealed the
potential for engineering protein folding properties that surpassed
those of their parental sequences. For example, a simple folding
interference screen was used to evolve sfGFP [7] from the ‘folding
reporter’ variant of GFP (frGFP) [14], that contained the cycle 3
mutations [2] and the ‘enhanced GFP’ mutations F64L and S65T
[15]. Importantly, several folding properties including improved
folding kinetics and resistance to aggregation were achieved
without disruption of the protein’s normal function. In fact,
expression of sfGFP was accompanied by a two-fold increase in
cellular fluorescence [7]. Likewise, in the case of the supercharged
GFP variants, resistance to aggregation was improved significantly
without affecting the proteins’ ability to fold or fluoresce [12]. In
general, by surpassing the physical and chemical properties of
naturally occurring proteins, such superproteins offer several
advantages including, for instance, increased capabilities as
biosensors [16] and FRET partners [9]; improved fidelity as
transcription reporters [17]; and improved therapeutic properties
(e.g., longer systemic half-life, improved efficacy) [6].
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sought to develop a general strategy for the discovery of
superfolded proteins. Specifically, we explored the hypothesis that
native cellular quality control pathways exert sufficient evolution-
ary pressure to improve protein folding properties beyond those
that are normally sufficient for solubility and function within a cell.
Along these lines, we previously developed a genetic selection for
protein solubility based on the inherent folding quality control
mechanism of the twin-arginine translocation (Tat) pathway that
results in exclusive export of correctly folded, soluble proteins
across the inner membrane in E. coli [18,19]. A similar and often
overlooked protein folding quality control also exists for the
general secretory (Sec) pathway (for a review see [20]). The Sec
export pathway is the most utilized secretion pathway in nearly all
bacteria [21]. Substrates of this pathway pass through the SecYEG
translocase and are exported in a post-translational manner with
the chaperone SecB, the signal peptide, and translocase itself
maintaining substrates in largely unfolded conformations to
minimize premature protein folding prior to translocation
[22,23,24]. Substrate proteins that fold prematurely in the
cytoplasm and become resistant to unfolding are often refractory
to post-translational Sec transport and are either degraded or, if
sufficiently stable, accumulate in the cytoplasm [25,26,27,28,29].
An ostensibly co-translational mode of SecYEG-mediated trans-
port is also possible via nascent substrate interaction with the
signal recognition particle (SRP) [30]. Here we report that the
protein folding quality control of SecYEG-mediated secretion is
capable of effectively discriminating between well-folded and
superfolded versions of GFP and, as a result, can be used for the
engineering of superfolded GFP variants with properties that are
unparalleled in their naturally occurring counterparts.
Results
Exploring the use of cellular folding quality control to
identify superfolded proteins
To facilitate directed evolution of superfolded proteins, our
initial goal was to develop a cellular screen for easily differentiating
between cells expressing frGFP and sfGFP. To begin, we
examined cytoplasmic expression of frGFP and sfGFP. Despite
the fact that the folding properties of sfGFP are far superior to
those of frGFP, there was only a small increase (65%) in the
geometric mean fluorescence of cells expressing sfGFP relative to
frGFP (Fig. 1a). This increase was due mostly to an increase in the
specific fluorescence of sfGFP rather than an increase in soluble
expression for the better folding mutant (see Table 1). Since we
desired a more pronounced difference in fluorescence emission
between sfGFP and frGFP to facilitate directed evolution by
fluorescence activated cell sorting (FACS), we explored whether
protein quality control associated with either the Tat or SecYEG-
mediated export pathways might be capable of yielding a more
striking difference in fluorescence for sfGFP and frGFP. While the
Tat pathway is known to modulate export efficiency of a substrate
based on folding and solubility [18,19], owing to the similar in vivo
solubility profiles of sfGFP and frGFP we observed only a modest
phenotypic difference between cells expressing sfGFP and frGFP
when each was targeted to the Tat pathway (data not shown).
Alternatively, we reasoned that proteins targeted for SecYEG
export would experience one or more of the following fates: (a)
accumulation in the periplasm if transport via SecYEG was
successful; (b) degradation in the cytoplasm if transport failed and
the protein was sensitive to proteolysis due to insufficient folding or
stability; and (c) accumulation in the cytoplasm if transport failed
but the protein was resistant to unfolding and proteolysis.
Additionally, for GFP export, the latter scenario is the only one
that would be expected to give rise to cellular fluorescence because
GFP that is routed into the periplasm through SecYEG is non-
fluorescent [31].
To experimentally test this notion, we targeted sfGFP and
frGFP for translocation via SecYEG by N-terminal fusions of each
to the DsbA (ssDsbA), maltose binding protein (ssMBP), and
alkaline phosphatase (ssPhoA) signal peptides. These three signal
peptides are derived from native E. coli substrates whose export is
SRP-dependent [30], SecB-dependent [32], and SecB-indepen-
dent [33], respectively. Upon induced expression of each fusion,
we observed a 67-, 47- and 24-fold greater fluorescence emission
for cells expressing ssDsbA-sfGFP, ssMBP-sfGFP and ssPhoA-
sfGFP fusions, respectively, relative to the corresponding frGFP
fusions (shown in Fig. 1b for ssDsbA and Supplemental Fig. S1a
and b for ssMBP and ssPhoA). We suspected that the strong
cellular fluorescence for sfGFP was a result of cytoplasmic
accumulation for this extremely well-folded protein. Indeed,
subcellular fractionation revealed that the fluorescence emitted
by cells expressing the sfGFP fusions was localized predominantly
in the cytoplasmic fraction (Fig. 1d) and that all of the sfGFP
constructs accumulated at a high level in the cytoplasm (Fig. 1d
and e, Supplemental Fig. S1c). It should be noted that a
measurable amount of both ssDsbA-sfGFP and ssMBP-sfGFP
localized in the periplasm but as expected [31], this material was
largely inactive. Though we were initially surprised that sfGFP was
able to accumulate in the cytoplasm when targeted for co-
translational export via the SRP-dependent ssDsbA, we suspect
that this was due to saturation of the SRP machinery [34] and not
because of re-routing to a post-translational (e.g., SecB) export
pathway (see also Supplemental Fig. S1d) as seen earlier for SRP
routing of MBP [30]. Because cytoplasmic ssDsbA-sfGFP folds
very rapidly and is resistant to unfolding, it is likely that cellular
quality control factors (e.g., proteases) are unable to eliminate this
protein and it accumulates in a fluorescent conformation. On the
other hand, ssDsbA-frGFP is efficiently degraded and does not
accumulate anywhere in cells (Supplemental Fig. S1e). Taken
together, the differential cytoplasmic stability of SecYEG-targeted
sfGFP and frGFP suggests that quality control can be used to easily
discriminate the folding behavior of these variants.
Exploiting SecYEG-mediated quality control to engineer
folding-enhanced proteins
To determine whether SecYEG-mediated quality control exerts
sufficient evolutionary pressure for engineering superproteins, we
attempted to evolve a superfolded version of the FACS-optimized
GFP variant known as GFPmut2. To create GFPmut2, Cormack
et. al. introduced random mutations to only 20 amino acids
flanking the chromophore of wildtype GFP and successfully
isolated a well-folded, FACS-optimized GFP variant (S65A/
V68L/S72A) [4]. Indeed, the fluorescence of cells expressing
GFPmut2 in the cytoplasm was nearly identical to that of cells
expressing sfGFP (Fig. 1a). However, cells expressing GFPmut2
targeted to SecYEG via ssDsbA were 46-fold less fluorescent than
cells expressing ssDsbA-sfGFP (Fig. 1b) and were comparable to
the low fluorescence seen earlier for those expressing ssDsbA-
frGFP. Notably, cells expressing ssMBP-GFPmut2 and ssPhoA-
GFPmut2 were also 36-fold and 4-fold less fluorescent, respec-
tively, than the corresponding sfGFP (Supplementary Figure S1a,
b).
Next, we sought to enhance the folding of ssDsbA-GFPmut2 so
that it would accumulate in the cytoplasm. Our first approach was
via direct fusion of GFPmut2 to thioredoxin-1 (TrxA), an
extremely well-folded protein known to fold too rapidly for Sec
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[35]. As expected, cell fluorescence was restored following
expression of a tripartite fusion of ssDsbA-TrxA-GFPmut2
(Fig. 1c); supporting our hypothesis that folding-enhancement of
SecYEG-targeted GFPmut2 can mediate cytoplasmic accumula-
tion of that protein. Encouraged by these observations, we next
attempted to evolve a folding-enhanced version of GFPmut2 by
rescuing cytoplasmic accumulation of SecYEG-targeted variants.
This approach accentuated the dependence of the fluorescent
phenotype on in vivo folding and was in stark contrast to the more
common strategy of evolving fluorescent proteins by optimizing in
vivo fluorescence from the direct expression of GFP, such as was
initially done for GFPmut2 [4] and ‘cycle 3’ GFP [2]. Because
ssDsbA fusions resulted in the greatest difference in fluorescence
between cells expressing sfGFP and GFPmut2 (46-fold), we chose
ssDsbA for our library evolution experiments. We cloned a high-
rate error-prone DNA library (4.8% amino acid error) of
GFPmut2 variants downstream of ssDsbA resulting in a diverse
Table 1. Yield, activity and folding parameters for the various GFPs.
GFP variant Culture yield (mg/L)
Fluorescence
yield (AU)
Equilibrium
unfolding, C1/2 (M)
Kinetic unfolding,
t1/2 (min)
Kinetic refolding,
t1/2 (min)
frGFP 13.8+/20.4 5.55+/20.01 4.37+/20.02 1.7+/20.7 73+/25
sfGFP 13.4+/20.2 7.10+/20.04 4.84+/20.04 1.5+/20.2 20+/22
GFPmut2 16.3+/20.4 5.06+/20.04 3.40+/20.06 0.4+/20.3 33+/22
P4 15.0+/20.4 4.42+/20.02 3.76+/20.03 0.5+/20.2 17+/23
P5 15.5+/20.3 4.38+/20.01 3.79+/20.04 6+/212 2 +/21
P7 (superfast) 15.0+/20.1 3.61+/20.04 5.06+/20.04 20+/231 1 +/21
doi:10.1371/journal.pone.0002351.t001
Figure 1. Flow cytometric analysis of GFP variants. Fluorescence histograms for cells expressing: superfolder GFP (sf, gray fill), folding reporter
GFP (fr, gray line), and GFPmut2 (mut2, black line) (a) without a signal peptide and a C-terminal 6xhis tag or (b) as an N-terminal fusion to the ssDsbA
signal peptide; (c) an N-terminal ssDsbA signal peptide fused to GFPmut2 (black line) and TrxA-GFPmut2 (gray fill). The geometric mean is listed next
to each histogram. There was no significant difference in growth rate between any of the cultures (data not shown). (d) Fluorescence (arbitrary units)
and subcellular localization of GFP as measured for cytoplasmic (cyt, grey bars) and periplasmic (per, white bars) fractions generated from cells
expressing the various ssDsbA-GFP fusions including sf, fr, mut2 and clones P1–P9. (e) Western blot analysis of the per and cyt fractions of cells
expressing the same fusions probed with GFP antiserum. Blots were probed with anti-GroEL serum as a fractionation marker.
doi:10.1371/journal.pone.0002351.g001
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6 variants. Following two rounds of FACS
we isolated 9 colonies that displayed fluorescent phenotypes
significantly above the continuum distribution. The sequences of
these variants revealed that: (a) all were full-length GFPmut2
variants fused in-frame to ssDsbA; and (b) all were unique with
distinct patterns in the amino acid substitutions (Fig. 2d).
Of the 35 total substitutions that were found, 7 specific
substitutions occurred more than once and accounted for 19 of
the 35 total substitutions. These recurring substitutions with
frequencies in parenthesis were: N105Y (46), F64L (46), E124V
(36), K101E (26), A206V (26), G232D (26) and V163A (26).
Some of the substitutions even appeared in combination multiple
times, for example N105Y/E124V (36) and even K101E/
N105Y/E124V/G232D (26). In just these 9 clones, we isolated
mutations that were uncovered in each previous folding-enhanced
variant of GFP: V163A is a cycle 3 mutation (we also found
M153K) [2], F64L is an enhanced GFP mutation [15], A206V
and Y145F are superfolder mutations [7] and our most common
mutation, N105Y, is found at the same residue as the N105T
superfolder mutation. Of the 11 reported substitutions in sfGFP,
we isolated mutations at 6 identical residues suggesting that our
collection of GFPmut2 variants represented bona fide folding-
enhanced versions of GFPmut2.
Characterization of the folding-enhanced GFPmut2
variants
To test whether these variants were in fact enhanced for folding,
we first re-transformed the recovered plasmids (clones P1–P9) into
fresh cells and observed that re-transformed cells expressing
variants P1–P9 all showed increased fluorescence relative to
ssDsbA-GFPmut2 (Fig. 2a) as a result of cytoplasmic accumulation
of each variant (Fig. 1d, e). We subcloned the variants appended
with a C-terminal 6x-histidine tag but without the coding region
for ssDsbA and observed that cells expressing these signal
sequence-less GFPmut2 variants showed little to no loss in
fluorescence activity when compared to the parental GFPmut2
protein (Fig. 2b), indicating that any improvement in GFP folding
(see below) was accomplished without significantly affecting the
proteins’ normal function.
We next chose to characterize clones P4, P5 and P7 in greater
detail because cells expressing ssDsbA fused to each yielded the
three highest whole-cell fluorescence values and collectively
contained six of the seven recurring substitutions mentioned
above. Following purification, we observed that P4, P5, and P7
had a slightly lower soluble yield and slightly lower total
fluorescence relative to GFPmut2 (Table 1), suggesting that these
clones represent a novel solution to protein folding optimization as
neither the function nor the soluble yield of the protein-of-interest
was improved. Since it has been shown in the past that fast-folding
proteins can be trapped in the cytoplasm during Sec transport [30]
and since sfGFP folds faster than frGFP [7], we reasoned that a
logical explanation for the cytoplasmic accumulation of P4, P5,
and P7 was increased folding kinetics. Indeed, following complete
unfolding, the refolding speed of variants P4 and P5 was
comparable to, while P7 far eclipsed, that of sfGFP (Fig. 3a,
Table 1). Since sfGFP was one of the fastest folding GFPs to date
[7], we renamed P7 ‘superfast’ GFP. In addition, P4, P5, superfast
GFP, and sfGFP all approached complete recovery during
refolding while frGFP and GFPmut2 stalled around 60% and
75% recovery, respectively.
Further, since mutations at N105 and A206 were previously
shown to have no effect on folding kinetics, we wondered if these
variants displayed increased resistance to chemical denaturation
[7]. We examined equilibrium unfolding and discovered that P4,
P5 and superfast GFP displayed increased stability relative to
GFPmut2 in the presence of GdnHCl (Fig. 3b, Table 1).
Surprisingly, frGFP displayed a modest stability during equilibri-
um unfolding suggesting that the evolved variants were not
Figure 2. Phenotype and genotype characterization of isolated GFPmut2 variants. Fluorescence histograms for cells expressing (a) N-
terminal ssDsbA fusions and (b) C-terminal 6xhis tag fusions to GFPmut2 (gray fill) and the variants P1 (black); P2 (green), P3 (blue), P4 (purple), P5
(light blue), P6 (yellow), P7 (red), P8 (brown) and P9 (orange). There was no significant difference in whole-cell fluorescence for cells expressing the
various GFPs with or without the 6xhis tag (data not shown). (c) Schematic representation of GFP scaffold with the 7 recurring substitutions
highlighted with black circles. In addition, all variants carry the GFPmut2 substitutions (S65A/V68L/S72A). (d) Substitutions found in clones P1–P9 with
the 7 recurring substitutions represented by crosses (top) and the shared superfolder mutations represented by asterisks (bottom).
doi:10.1371/journal.pone.0002351.g002
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stability. Intrigued by this observation, we examined the kinetics of
unfolding and discovered that superfast GFP and P5 unfolded very
slowly whereas P4 unfolded at a speed comparable to GFPmut2
(Fig. 3c, Table 1). Thus, while we conclude that each of these
variants appears to have been isolated primarily based on
improved folding kinetics, laboratory evolution returned three
unique responses to the pressure imposed by secretory quality
control: improved folding kinetics (P4); improved folding kinetics
and slower unfolding (P5); and improved folding kinetics, slower
unfolding, and increased stability during equilibrium unfolding
(superfast GFP).
Discussion
Numerous lines of evidence have revealed the existence of a
multi-component folding quality control system that regulates the
export of proteins out of the bacterial cytoplasm [20]. One
instance of this sort of quality control exists for Tat export, which
we previously exploited for the development of a high-throughput
genetic selection for protein solubility [19]. In the present study,
we have demonstrated that laboratory evolution combined with
the folding quality control inherent to SecYEG-mediated export
enables sampling of largely unexplored amino-acid sequences for
the discovery of artificial, high-performance proteins with
properties that are unparalleled in their naturally occurring
analogues. As briefly demonstrated with TrxA (see Fig. 1c), we
are optimistic that the SecYEG-mediated folding quality control
may extend to at least some other protein targets. In this case, a
general strategy for evolving folding-enhanced versions of these
proteins may be possible by assaying for cytoplasmic accumulation
of a target protein fused to a reliable cytoplasmic reporter protein
[36,37], protein fragment [9,38,39], or peptide [40,41] that could
be coupled with SecYEG targeting to create superfolders on
demand.
Despite the potential for isolating superfolder GFPs, an
unresolved question that arises is: what are the underlying cellular
factors that govern whether a substrate is degraded or retained in
the cytoplasm, especially for non-native substrates? Historically, it
has been observed that during secretion various heterologous
proteins are rapidly degraded [25] and various proteases play a
role in this process [42,43]. Recently, de Gier and coworkers
observed that overexpressed native SRP substrates accumulate in
the cytoplasm by titrating out targeting components (e.g. SRP and
FtsY); these ‘overflow’ substrates become susceptible to degrada-
tion and inclusion body formation in the cytoplasm [34]. We
observed a similar overflow in that the fluorescence of cells
expressing ssDsbA fused to P4, P5, and P7 was dependent on
overexpression, as constitutive expression from the trc promoter
(i.e., no inducer) showed no appreciable cell fluorescence (data not
shown). It is possible that certain overflow SRP substrates,
particularly membrane proteins, accumulate in the cytoplasm by
forming inclusion bodies. Overflow ssDsbA-sfGFP may accumu-
late in the cytoplasm by folding rapidly to evade degradation,
while overflow ssDsbA-frGFP is efficiently eliminated. Thus, there
likely exists a kinetic competition between folding and degradation
of overflow SRP substrates, suggesting that the cytoplasmic
accumulation of an SRP-dependent protein is linked to both
SRP saturation and quality control. As such, care needs to be
taken to avoid further saturating the quality control machinery.
The ability to broadly exploit this quality control feature in the
future will likely depend on optimizing promoter/induction
conditions. There are several aspects of SecYEG-mediated
secretion that may play a concerted role in the quality control of
GFP (e.g. interactions with the signal peptide or translocon,
chaperone or protease recruitment, compatibility with the inner
membrane). However one thing is certain, when fast-folding GFP
mutants are appended with a signal peptide targeting them for
secretion via SecYEG, these proteins accumulate in the cytoplasm
and confer a strong fluorescent phenotype to cells that is not
present in the case of non-superfolding GFPs.
Finally to answer our initial query: is it inherently difficult to
engineer folding-enhanced variants of GFP or are methods of
screening and selecting lacking? Based on the relative ease with
which we engineered folding-enhanced variants of GFPmut2, the
answer appears to be a lack of robust screening methods. For
instance, a single round of mutagenesis and two rounds of FACS
yielded superfolded clones P4, P5, and superfast GFP that each
exhibited significant folding-enhancement relative to the parental
GFPmut2 protein. However, the isolation of these clones would
not have been possible without the exploitation of SecYEG-
mediated quality control as a screening platform; rather, we would
have remained stalled at the self-imposed ‘glass-ceiling’ of
functional advantage.
Materials and Methods
Bacterial strains and plasmids
E. coli strain MC4100 was used for all experiments, except for
the library which was in DH5a. All plasmids were derivatives of
Figure 3. In vitro characterization of GFP folding. (a) Kinetic refolding measured as fraction folded (Ff) over time, (b) equilibrium unfolding
measured as Ff versus GdnHCl molarity and (c) kinetic unfolding measured as Ff over time for the different GFP variants as indicated. Curve fits were
added as a visual aid. All data is the average of three replicate experiments where the standard error for all data was ,10%.
doi:10.1371/journal.pone.0002351.g003
Evolution of Fast-Folding GFP
PLoS ONE | www.plosone.org 5 June 2008 | Volume 3 | Issue 6 | e2351pTrc99A (Amp
R) (Amersham Pharmacia). For protein expression,
GFP variants were appended with a 6xHis tag and cloned between
XbaI and HindIII. The coding sequences for the signal peptides
were PCR amplified from MC4100 chromosomal DNA and
cloned into pTMB (Cm
R) [19] between SacI and XbaI. The GFP
variants were cloned between XbaI and HindIII. The coding
regions for GFPmut2 [4], frGFP [14], and sfGFP [7] were PCR
amplified from pTGS [44], pCS-GFP (kindly provided by G.
Waldo) [14], and pCR4Blunt-TOPO-superfolder_GFP (Geneart
AG), respectively. Libraries of GFPmut2 were synthesized using
the mutagenic method of Fromant et al. [45] and inserted in-frame
with the coding region for the DsbA signal peptide. Plasmids were
confirmed by DNA sequencing. Antibiotic selection was main-
tained at: ampicillin, 100 mg/ml; chloramphenicol (Cm), 20 mg/
ml.
Cell culture and in vivo fluorescence analysis
Overnight cultures were diluted 1:100 into fresh LB medium
with Cm or Amp at 37uC and induced with 100 mM IPTG in the
early-exponential phase. At 4 h of induction, 10 mL of cells were
diluted into 1 ml of PBS and analyzed by a flow cytometer
(FACSCalibur; Becton Dickinson Biosciences). All flow cytometric
analysis was performed with 488 nm excitation. For fluorescence
activated cell sorting (FACS), the population was gated by side
scatter (488/10 nm), forward scatter (488/10 nm), and fluores-
cence emission (530/30 nm) windows. Approximately ,4.1610
6
DH5a library cells (diversity ,1.5610
6) were subjected to FACS.
The collected solution was sterile filtered (0.45-mm pore;
Millipore), and placed on LB/Cm plates. 3,023 colonies were
recovered, scraped, and inoculated into a fresh culture for a
second round of FACS. 192 individual colonies were recovered in
200 mL LB/Cm in 96-well plates. The next day, cells were diluted
1:100 into LB/Cm/IPTG, grown, and screened via a fluorescent
microplate reader (Bio-Tek Synergy HT; Bio-Tek Instruments);
excitation 485/20 nm, emission 528/20 nm. Plasmids were
recovered and sequenced from selected clones.
Protein isolation
Cultures were normalized by absorbance (600 nm) and
fractionated using the ice-cold osmotic shock procedure [18,46].
Western blotting of these fractions was performed [18]. Samples
were read on a fluorescent microplate reader. For in vitro folding,
native protein was purified on Ni-NTA columns according to the
manufacturer’s specifications (Ni-NTA Fast Start Kit, QIAGEN).
Samples were concentrated and recovered in PBS buffer according
to manufacturer’s specifications (VivaSpin 6, Viva Science). SDS-
PAGE was performed to verify binding efficiency. A Bio-Rad
Protein Assay was used to quantify purified protein (Bio-Rad).
Protein folding analysis
Equilibrium unfolding experiments were performed in 96-well
plates at a protein concentration of 33 mg/mL with guanidinium
chloride (GdnHCl) in TNG buffer (25 mM Tris [pH 7.5], 0.2 M
NaCl, 5% glycerol) supplemented with 1mM dithiothreitol (DTT).
C1/2 values were determined by fitting the curves at 24 h in
Microsoft Excel as described [7]. Three trials were averaged and
the error bars represent plus or minus the standard deviation.
Manual mixing kinetic unfolding experiments were performed by
rapid dilution into 6.8 M GdnHCl TNG buffer (33 mg/mL
protein). Manual mixing kinetic refolding experiments were
performed by rapid 10-fold dilution of fully unfolded samples into
fresh TNG buffer (1 mM DTT) without GdnHCl (3.3 mg/mL
protein and 0.68 M GdnHCl). The initial readings were taken
prior to addition of buffer and every eleven seconds thereafter
(dead time=21 s). Three trials were averaged. For readability,
every seventh data point is shown and the standard error is not
shown (avg. ,10%). t1/2 values were determined by fitting the
unfolding kinetic curves to double exponential decay (frGFP,
sfGFP, GFPmut2, P4) and triple exponential decay (P5 and
superfast GFP (P7)). During kinetic refolding t1/2 was the first time
point at which half of the fluorescence was recovered. In each case,
native samples were diluted into an equivalent volume of TNG
buffer and read identically. The fraction folded, Ff, is the
fluorescence of the experimental divided by the native sample at
each time point to correct for the minimal effects of dilution and
photobleaching.
Supporting Information
Figure S1
Found at: doi:10.1371/journal.pone.0002351.s001 (1.77 MB TIF)
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